Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects humans through the binding of the spike prote...
Autor principal: | |
---|---|
Formato: | Research protocol information |
Publicado: |
2020-04-10
|
Materias: | |
Acceso en línea: | https://doi.org/10.3390/v12040428 https://hdl.handle.net/20.500.12663/1204 |
id |
PAO-20.500.12663-1204 |
---|---|
record_format |
dspace |
spelling |
He, Jiahua et al. 2020-04-24T18:03:13Z 2020-04-24T18:03:13Z 2020-04-10 https://doi.org/10.3390/v12040428 https://hdl.handle.net/20.500.12663/1204 The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects humans through the binding of the spike protein to ACE2. Here, we have systematically studied the molecular mechanisms of human infection with SARS-CoV-2 and SARS-CoV by protein-protein docking and MD simulations. It was found that SARS-CoV-2 binds ACE2 with a higher affinity than SARS-CoV, which may partly explain that SARS-CoV-2 is much more infectious than SARS-CoV. In addition, the spike protein of SARS-CoV-2 has a significantly lower free energy than that of SARS-CoV, suggesting that SARS-CoV-2 is more stable and may survive a higher temperature than SARS-CoV. This provides insights into the evolution of SARS-CoV-2 because SARS-like coronaviruses have originated in bats. Our computation also suggested that the RBD-ACE2 binding for SARS-CoV-2 is much more temperature-sensitive than that for SARS-CoV. Thus, it is expected that SARS-CoV-2 would decrease its infection ability much faster than SARS-CoV when the temperature rises. These findings would be beneficial for the disease prevention and drug/vaccine development of SARS-CoV-2. English COVID-19 Coronavirus Infectious Diseases SARS-CoV-2 Molecular Structure Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 Viruses Others Virus: natural history, transmission and diagnostics Research protocol information Save Lives / Salvar Vidas |
elec_str_mv |
Organización Panamericana de la Salud |
collection |
Organización Panamericana de la Salud |
title |
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 |
spellingShingle |
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 He, Jiahua et al. COVID-19 Coronavirus Infectious Diseases SARS-CoV-2 Molecular Structure |
title_short |
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 |
title_full |
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 |
title_fullStr |
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 |
title_full_unstemmed |
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 |
title_sort |
molecular mechanism of evolution and human infection with sars-cov-2 |
author |
He, Jiahua et al. |
author_facet |
He, Jiahua et al. |
topic |
COVID-19 Coronavirus Infectious Diseases SARS-CoV-2 Molecular Structure |
topic_facet |
COVID-19 Coronavirus Infectious Diseases SARS-CoV-2 Molecular Structure |
publishDate |
2020-04-10 |
format |
Research protocol information |
description |
The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects humans through the binding of the spike protein to ACE2. Here, we have systematically studied the molecular mechanisms of human infection with SARS-CoV-2 and SARS-CoV by protein-protein docking and MD simulations. It was found that SARS-CoV-2 binds ACE2 with a higher affinity than SARS-CoV, which may partly explain that SARS-CoV-2 is much more infectious than SARS-CoV. In addition, the spike protein of SARS-CoV-2 has a significantly lower free energy than that of SARS-CoV, suggesting that SARS-CoV-2 is more stable and may survive a higher temperature than SARS-CoV. This provides insights into the evolution of SARS-CoV-2 because SARS-like coronaviruses have originated in bats. Our computation also suggested that the RBD-ACE2 binding for SARS-CoV-2 is much more temperature-sensitive than that for SARS-CoV. Thus, it is expected that SARS-CoV-2 would decrease its infection ability much faster than SARS-CoV when the temperature rises. These findings would be beneficial for the disease prevention and drug/vaccine development of SARS-CoV-2.
|
url |
https://doi.org/10.3390/v12040428 https://hdl.handle.net/20.500.12663/1204 |
work_keys_str_mv |
AT hejiahuaetal molecularmechanismofevolutionandhumaninfectionwithsarscov2 |
_version_ |
1737882963132022784 |